Methods and compositions for treatment of a genetic condition
Abstract:
Methods and compositions comprising a CRISPR/Cas nuclease that cleaves a T cell receptor (TCR) gene and/or human leukocyte (HLA) gene, the nuclease comprising a cleavage domain and a single guide RNA that binds to a target site in the TCR and/or HLA gene.
Public/Granted literature
Information query
Patent Agency Ranking
0/0